Meeting
2015 ASCO Annual Meeting
Association of higher lung dose received during total body irradiation for allogeneic hematopoetic stem cell transplantation in children with acute lymphoblastic leukemia with inferior progression-free and overall survival: A report from the Children’s Oncology Group.
Authors
Natia Esiashvili
Emory Univ, Atlanta, GA
Natia Esiashvili , Xiaomin Lu , Stephen Hunger , Thomas E. Merchant , Patrick Andrew Brown , Donna Ann Wall , Stephan A. Grupp , Michael Pulsipher
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Leukemia/Lymphoma
Clinical Trial Registration Number
NCT00382109
Citation
J Clin Oncol 33, 2015 (suppl; abstr 10030)
DOI
10.1200/jco.2015.33.15_suppl.10030
Abstract #
10030
Poster Bd #
100
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Long-term survival of adults with B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) after treatment with blinatumomab and subsequent allogeneic hematopoietic stem cell transplantation (HSCT).
First Author: Max Topp
Poster
2021 ASCO Annual Meeting
A registry-based, observational safety study of inotuzumab ozogamicin (InO) treatment in patients (pts) with B-cell precursor acute lymphoblastic leukemia (ALL) who proceeded to hematopoietic stem cell transplant (HSCT).
First Author: Marcos J.G. De Lima
Poster
2021 ASCO Annual Meeting
Late cardiac events and their impact on overall survival in patients receiving an allogeneic stem cell transplant.
First Author: Christine Auberle
Poster
2019 ASCO Annual Meeting
A phase II study of myeloablative allogeneic hematopoietic stem cell transplantation (aHSCT) for acute lymphoblastic leukemia (ALL) in older patients using fludarabine and total body irradiation (Flu/TBI).
First Author: Omer Hassan JAMY